TOI Key Statistics, Chart & Performance
The current stock price of TOI is 3.16 USD. In the past month the price decreased by -32.48%. In the past year, price increased by 1850.62%.
TOI Latest News, Press Relases and Analysis
TOI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 19.94 | 120.70B | ||
| THC | TENET HEALTHCARE CORP | 14.08 | 19.30B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 11.72 | 15.51B | ||
| EHC | ENCOMPASS HEALTH CORP | 22.47 | 11.70B | ||
| ENSG | ENSIGN GROUP INC/THE | 30.05 | 10.82B | ||
| PACS | PACS GROUP INC | 41.82 | 4.93B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 16.93 | 2.71B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.67B | ||
| SGRY | SURGERY PARTNERS INC | 21.65 | 2.17B | ||
| NHC | NATIONAL HEALTHCARE CORP | 20.56 | 2.14B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 18.1 | 1.93B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 6.4 | 1.53B |
Related stock screener links
About TOI
Company Profile
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Company Info
ONCOLOGY INSTITUTE INC/THE
18000 Studebaker Rd, Suite 800
Cerritos CALIFORNIA US
CEO: Steven Hochberg
Employees: 825
Phone: 15627353226
ONCOLOGY INSTITUTE INC/THE / TOI FAQ
Can you describe the business of ONCOLOGY INSTITUTE INC/THE?
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
What is the current price of TOI stock?
The current stock price of TOI is 3.16 USD. The price increased by 3.95% in the last trading session.
Does ONCOLOGY INSTITUTE INC/THE pay dividends?
TOI does not pay a dividend.
What is the ChartMill rating of ONCOLOGY INSTITUTE INC/THE stock?
TOI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for TOI stock?
7 analysts have analysed TOI and the average price target is 7.14 USD. This implies a price increase of 125.95% is expected in the next year compared to the current price of 3.16.
What is the market capitalization of TOI stock?
ONCOLOGY INSTITUTE INC/THE (TOI) has a market capitalization of 295.46M USD. This makes TOI a Micro Cap stock.
Can you provide the upcoming earnings date for ONCOLOGY INSTITUTE INC/THE?
ONCOLOGY INSTITUTE INC/THE (TOI) will report earnings on 2026-03-23, after the market close.
TOI Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to TOI. When comparing the yearly performance of all stocks, TOI is one of the better performing stocks in the market, outperforming 99.92% of all stocks.
TOI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TOI. TOI has a bad profitability rating. Also its financial health evaluation is rather negative.
TOI Financial Highlights
Over the last trailing twelve months TOI reported a non-GAAP Earnings per Share(EPS) of -0.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TOI Forecast & Estimates
7 analysts have analysed TOI and the average price target is 7.14 USD. This implies a price increase of 125.95% is expected in the next year compared to the current price of 3.16.
For the next year, analysts expect an EPS growth of 38.52% and a revenue growth 29.38% for TOI